Fig. 4From: ABCB1 and ABCG2 restricts the efficacy of gedatolisib (PF-05212384), a PI3K inhibitor in colorectal cancer cellsGedatolisib stimulated the ATPase of ABCB1 and ABCG2. a Effect of gedatolisib on the ATPase activity of ABCB1. b Effect of gedatolisib on the ATPase activity of ABCG2. Data were shown as mean ± SD, which is representative for three independent experiments. Asterisk presents when p value is < 0.05Back to article page